Phase 1 study of Blu-285 in advanced systemic mastocytosis
10 Dec 2017
Phase 1 study of Blu-285 in advanced systemic mastocytosis
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma
New treatments for acute myeloid leukaemia
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma
Long term follow up on the ZUMA-1 trial for nHL
BLU-285 for advanced systemic mastocytosis
Dexamethasone and the UKALL 2011 trial
The importance of data connectivity and e-health
A world wide web for genomic data
The reality of pancreatic cancer
Personalised medicine for inherited breast cancer